Phosphate binders in chronic kidney disease: The positions of sevelamer

被引：0
作者：
Fomin, V. V.
Shilov, E. M.
Svistunov, A. A.
Milovanov, Yu. S.
机构：
来源：
TERAPEVTICHESKII ARKHIV | 2013年 / 85卷 / 06期
关键词：
chronic kidney disease; hyperphosphatemia; phosphate binders; sevelamer; CORONARY-ARTERY CALCIFICATION; RANDOMIZED-TRIAL; VASCULAR CALCIFICATION; CALCIUM ACETATE; CKD PATIENTS; HEMODIALYSIS; HYPERPHOSPHATEMIA; DIALYSIS; MORTALITY; CARBONATE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The paper shows the role of phosphate binders in the correction of phosphorus and calcium metabolic disturbances in chronic kidney disease. The results of clinical trials demonstrating the efficacy and safety of sevelamer are discussed.
引用
收藏
页码：96 / 99
页数：4
相关论文
共 33 条
[1]   Hyperphosphataemia - a silent killer of patients with renal failure? [J].
Amann, K ;
Gross, ML ;
London, GM ;
Ritz, E .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (09) :2085-2087
[2]  
Bernard Lisa, 2013, J Med Econ, V16, P1, DOI 10.3111/13696998.2012.718019
[3]   Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients [J].
Block, G. A. ;
Raggi, P. ;
Bellasi, A. ;
Kooienga, L. ;
Spiegel, D. M. .
KIDNEY INTERNATIONAL, 2007, 71 (05) :438-441
[4]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824
[5]   Survival in end stage renal disease: calcium carbonate vs. sevelamer [J].
Borzecki, A. M. ;
Lee, A. ;
Wang, S. W. ;
Brenner, L. ;
Kazis, L. E. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (06) :617-624
[6]  
Chertow GM, 1999, CLIN NEPHROL, V51, P18
[7]   Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients [J].
Chertow, GM ;
Burke, SK ;
Raggi, P .
KIDNEY INTERNATIONAL, 2002, 62 (01) :245-252
[8]  
Draca N., 2013, MED HYPOTHESES
[9]   On the evolving nature of understanding dialysis-related disorders [J].
Eknoyan, G ;
Lindberg, JS .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) :S1-S3
[10]   Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients [J].
Ferramosca, E ;
Burke, S ;
Chasan-Taber, S ;
Ratti, C ;
Chertow, GM ;
Raggi, P .
AMERICAN HEART JOURNAL, 2005, 149 (05) :820-825
1234